Abstract OT2-06-01: Highly innovative personalized RNA-immunotherapy for patients with triple negative breast cancerM Schmidt, Uğur Şahin, Mustafa Diken et al.|Cancer Research|2019Cited by 10
Abstract CT020: MERIT: introducing individualized cancer vaccines for the treatment of TNBC - a phase I trialSandra Heesch, Uğur Şahin, Valesca Bukur et al.|Cancer Research|2016Cited by 5
Abstract CT201: The Mutanome Engineered RNA Immuno-Therapy (MERIT) projectSandra Heesch, Uğur Şahin, Cedrik M. Britten et al.|Cancer Research|2015Cited by 1